目的研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗,可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
应用推荐